CAREDX INC's ticker is CDNA and the CUSIP is 14167L103. A total of 1 filers reported holding CAREDX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,325 | -98.5% | 475 | -98.1% | 0.00% | -98.2% |
| Q2 2023 | $216,538 | -7.0% | 25,475 | 0.0% | 0.16% | -10.4% |
| Q1 2023 | $232,842 | -19.9% | 25,475 | 0.0% | 0.18% | -16.9% |
| Q4 2022 | $290,670 | -35.7% | 25,475 | -4.1% | 0.22% | -43.3% |
| Q3 2022 | $452,000 | -20.8% | 26,575 | 0.0% | 0.39% | -15.9% |
| Q2 2022 | $571,000 | -41.9% | 26,575 | 0.0% | 0.46% | -30.1% |
| Q1 2022 | $983,000 | -18.7% | 26,575 | 0.0% | 0.66% | -14.2% |
| Q4 2021 | $1,209,000 | -29.4% | 26,575 | -1.7% | 0.77% | -39.2% |
| Q3 2021 | $1,712,000 | -30.6% | 27,023 | +0.2% | 1.26% | -30.5% |
| Q2 2021 | $2,468,000 | +34.1% | 26,962 | -0.2% | 1.81% | +23.7% |
| Q1 2021 | $1,840,000 | -7.9% | 27,025 | -2.0% | 1.47% | -14.6% |
| Q4 2020 | $1,998,000 | +62.7% | 27,576 | -14.8% | 1.72% | +55.2% |
| Q3 2020 | $1,228,000 | +109.9% | 32,358 | +95.8% | 1.11% | +72.0% |
| Q2 2020 | $585,000 | – | 16,523 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,024,515 | $37,897,000 | 17.98% |
| GAGNON SECURITIES LLC | 917,220 | $33,928,000 | 5.53% |
| Gagnon Advisors, LLC | 277,347 | $10,259,000 | 4.73% |
| First Light Asset Management, LLC | 722,073 | $26,709,000 | 2.36% |
| NEXT CENTURY GROWTH INVESTORS LLC | 627,052 | $23,194,000 | 2.32% |
| Casdin Capital, LLC | 1,153,335 | $42,662,000 | 1.91% |
| PERKINS CAPITAL MANAGEMENT INC | 57,692 | $2,134,000 | 1.75% |
| Zweig-DiMenna Associates LLC | 233,374 | $8,633,000 | 1.15% |
| Bellevue Group AG | 2,311,176 | $85,490,000 | 0.99% |
| G2 Investment Partners Management LLC | 94,779 | $3,506,000 | 0.83% |